UBI29-41

UBI29-41, also known as the C-terminal fragment of ubiquicidin, is a synthetic antimicrobial peptide derived from the human ubiquicidin protein. Renowned for its strong affinity toward bacterial membranes and its selective targeting of microbial cells, UBI29-41 has become a valuable research tool in the fields of microbiology, molecular imaging, and drug discovery. The peptide's amphipathic nature and positive charge enable it to interact efficiently with the negatively charged components of bacterial cell walls, making it an ideal candidate for the development of diagnostic and investigative technologies. Its relatively short sequence provides ease of synthesis and versatility for chemical modification, allowing researchers to tailor the peptide for specific experimental needs. UBI29-41's unique properties have led to its widespread adoption in studies seeking to advance our understanding of host-pathogen interactions and to innovate new methodologies for pathogen detection.

Microbial Imaging: UBI29-41 is extensively utilized as a molecular probe in the imaging of bacterial infections. By conjugating the peptide with various fluorescent dyes or radiolabels, researchers can visualize and localize bacterial colonies in vitro and in vivo with high specificity. Its ability to bind preferentially to bacterial membranes—while exhibiting minimal affinity for mammalian cells—enables precise detection of infection sites. This application is particularly valuable in preclinical research, where rapid and accurate identification of pathogens is critical for studying disease progression and evaluating the efficacy of antimicrobial agents. The use of UBI29-41-based imaging agents has significantly improved the resolution and sensitivity of non-invasive diagnostic techniques, facilitating early intervention strategies and advancing the field of infectious disease research.

Antimicrobial Mechanism Studies: The peptide serves as an important model for investigating the mechanisms underlying antimicrobial activity. Researchers employ UBI29-41 in assays designed to elucidate the processes by which cationic peptides disrupt bacterial cell membranes, induce pore formation, and cause cell lysis. By analyzing the interaction of this peptide with various bacterial strains, scientists can gain valuable insights into the structural features that govern selectivity and potency. These studies not only deepen our understanding of innate immune defense mechanisms but also inform the rational design of next-generation antimicrobial compounds. The versatility of UBI29-41 in mechanistic research underscores its significance in combating antibiotic resistance and fostering the development of novel therapeutic strategies.

Pathogen Detection Platforms: UBI29-41 has been incorporated into a range of biosensor technologies aimed at the rapid and sensitive detection of pathogenic bacteria. By immobilizing the peptide on sensor surfaces, researchers can create platforms that selectively capture and identify target microbes from complex biological samples. This approach leverages the peptide's strong binding affinity to enhance the specificity and speed of detection, offering a powerful alternative to traditional culture-based methods. Such biosensors have found applications in food safety, environmental monitoring, and clinical diagnostics research, where timely and accurate identification of pathogens is paramount. The integration of UBI29-41 into these platforms continues to drive innovation in microbial detection technologies.

Peptide Engineering and Conjugation: The modular structure of UBI29-41 makes it an attractive scaffold for peptide engineering efforts. Scientists frequently modify its sequence to optimize stability, enhance selectivity, or introduce functional groups for conjugation with imaging agents, nanoparticles, or therapeutic molecules. These engineered variants expand the utility of the peptide, enabling its use in targeted delivery systems and multifunctional research tools. The adaptability of UBI29-41 supports the development of customized solutions for complex experimental challenges, demonstrating its value as a foundational component in peptide-based research and technology development.

Host-Pathogen Interaction Research: UBI29-41 is instrumental in studies exploring the dynamics of host-pathogen interactions at the molecular level. By tracking the peptide's localization and binding behavior, researchers can map the spatial distribution of bacteria within host tissues and investigate the factors influencing microbial colonization and immune response. This application provides critical information for deciphering the mechanisms of infection and immunity, paving the way for the identification of novel targets for antimicrobial intervention. The use of UBI29-41 in these research contexts highlights its essential role in advancing our understanding of infectious diseases and supporting the discovery of innovative solutions for pathogen control.

1. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

2. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

4. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy